Surgery Grand Rounds

October 8, 2014

Duke North – Room 2002

 

Surgical D & C Case Conference*

6:00 – 7:00 a.m.

Moderator: Debra Sudan, M.D.

 

*Surgical D & C Conference should be attended by Faculty, Fellows, Residents, and APPs only.

 

Surgical Grand Rounds

 

7:00 – 8:00 a.m.

Nucleic Acid Aptamers and Scavengers for Treating Thrombosis and Inflammation

 

Bruce A. Sullenger, Ph.D.

Professor of Surgery

Division of Surgical Sciences

Professor of Pharmacology and Cancer Biology

Associate Professor in Molecular Genetics and Microbiology

Director of the Duke Center for Translational Research

 

Moderator:  Jeffrey Lawson, M.D., Ph.D.

 

 

Presenter Disclosure of Financial Relationships:  Dr. Sullenger indicates that he is a Board member and Scientific Founder for b3 Bio, Inc. and an Advisory Board Member for Regado Biosciences, Inc., but has no personal/financial relationships to disclose which are relative to this activity.  Dr. Debra Sudan indicates that she does not have any disclosures and no personal/financial relationships to disclose which are relative to this activity.  Dr. Lawson indicates that he is a Principal Investigator for Baxter, Humacyte, and Proteon; a Consultant for Cryolife and Hemosphere; and a Speaker for W. L. Gore, but has no personal/financial relationships to disclose which are relative to this activity.

RSS Activity Medical Director(s) Disclosure: Dr. Ranjan Sudan has no personal/financial relationships to disclose which are relative to this activity.

---Global Learning Objectives---

  1. Review and discuss new advances in general surgery;
  2. Present and discuss case studies, protocols, treatment guidelines and surgical/pathology report appropriate to General Surgery practice;
  3. Review and discuss clinical research findings and other evidence from pertinent literature.

 

---Accreditation Information---

The Duke University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

---Unapproved Use Disclosure---

Duke School of Medicine requires CME faculty (speakers) to disclose to the attendees: 1) When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (Not FDA approved) ; and 2) Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and /or unsupported opinion.  Faculty at this event may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling.  This information is intended solely for continuing medical education, and is not intended to promote off-label use of these medications.  If you have any questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

 

---Credit Designation---

The Duke University School Of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in this activity.

 

In order to receive CME Credit, learners must sign in at the beginning of this event.

 

Description: Duke_Surgery_cmykweb

Location: 
DN 2002
United States
Session date: 
10/08/2014 - 6:00am to 8:00am EDT

Please login or register to take this course.
Speaker Name: 
Bruce A. Sullenger, Ph.D.